Press Releases & Awards Archives | MicroGen Diagnostics

January 24, 2018

Dr. Dean Tortorelis (at left) and Dr. Joseph Cerny

January 24, 2018

More than meets the eye: Innovative technology spots bacteria previously undetected

Two Robbinsdale urologists leading the way regionally in treating chronic infections By LACI GAGLIANO [email protected] Two physicians in the Urology Associates group at North Memorial Health Hospital, Dr. Joseph Cerny and Dr. Dean Tortorelis, have harnessed cutting-edge technology, used by National Aeronautics and Space Administration on the Martian Rover, to get a leg up on hidden strains of bacteria that are responsible for recurrent urinary tract and prostate infections. The science behind the technology is far more earthbound than it sounds. Based in a laboratory in Lubbock, Texas, MicroGenDX is the innovative testing technology that has enabled Cerny and Tortorelis […]

May 16, 2019

May 16, 2019

MicroGenDX’s Next-Generation DNA Sequencing Ushers in New Era of Advanced Infection Diagnostics at 2019 American Academy of Orthopedic Surgeons with Multiple Podium Talks

MicroGenDX, the world leader in Next Generation DNA Sequencing (NGS) in microbial identification took the podium an unprecedented three times at the largest and most reputable orthopedic conference in the world held by the American Academy of Orthopedic Surgeons (AAOS).

February 7, 2020

MicroGenDX Next-Generation DNA Sequencing to Take Center Stage at American Association of Hip and Knee Surgeons to Reveal New Findings in Periprosthetic Joint Infection

MicroGenDX Laboratories equipped a multicenter study with its gold standard NGS test to investigate the persistence of Periprosthetic Joint Infection (PJI). Renowned orthopedic surgeon Javad Parvizi, MD will take the podium at American Association of Hip and Knee Surgeons (AAHKS) to discuss results of the study to show how NGS is revolutionizing the microbial diagnosis of chronic infections in orthopedics. Click Here to Read Full Article…

February 7, 2020

MicroGenDX Next-Gen DNA Sequencing Used in Breakthrough Knee Infection Study: Rothman Institute Accepts Eastern Orthopaedic Association’s Musculoskeletal Infection Award

MicroGenDX, the world leader in providing Next Generation DNA Sequencing (NGS) in microbial identification, processed samples in the groundbreaking study “Next Generation Sequencing for the Diagnosis of Periprosthetic Knee Infection: A Multicenter Investigation” led by the Rothman Institute. The study recently accepted the Eastern Orthopaedic Association’s Musculoskeletal Infection Award and further evidenced that advanced molecular diagnostic testing gives hope to patients suffering from devastating chronic infections. Click Here to Read Full Article…